13 results on '"Katelyn D. Miller"'
Search Results
2. Data from Targeting ACSS2 with a Transition-State Mimetic Inhibits Triple-Negative Breast Cancer Growth
- Author
-
Zachary T. Schug, Joseph M. Salvino, Andrew V. Kossenkov, Emmanuel Skordalakes, Joel Cassel, Yellamelli V.V. Srikanth, Tomas M. Aramburu, Jessica C. Casciano, Jesse N. Velasco-Silva, Joshua D. Shaffer, Sara B. Papp, Caroline E. Perry, Katherine Pniewski, and Katelyn D. Miller
- Abstract
Acetyl-CoA is a vitally important and versatile metabolite used for many cellular processes including fatty acid synthesis, ATP production, and protein acetylation. Recent studies have shown that cancer cells upregulate acetyl-CoA synthetase 2 (ACSS2), an enzyme that converts acetate to acetyl-CoA, in response to stresses such as low nutrient availability and hypoxia. Stressed cancer cells use ACSS2 as a means to exploit acetate as an alternative nutrient source. Genetic depletion of ACSS2 in tumors inhibits the growth of a wide variety of cancers. However, there are no studies on the use of an ACSS2 inhibitor to block tumor growth. In this study, we synthesized a small-molecule inhibitor that acts as a transition-state mimetic to block ACSS2 activity in vitro and in vivo. Pharmacologic inhibition of ACSS2 as a single agent impaired breast tumor growth. Collectively, our findings suggest that targeting ACSS2 may be an effective therapeutic approach for the treatment of patients with breast cancer.Significance:These findings suggest that targeting acetate metabolism through ACSS2 inhibitors has the potential to safely and effectively treat a wide range of patients with cancer.
- Published
- 2023
3. Murine BST2/tetherin promotes measles virus infection of neurons
- Author
-
Carli B. Jones, Riley Williams, Katelyn D. Miller, Glenn F. Rall, and Christine M. Matullo
- Subjects
Antiviral protein ,Article ,Virus ,Measles virus ,Mice ,Antigens, CD ,Interferon ,Virology ,medicine ,Animals ,Mice, Knockout ,Neurons ,Host cell membrane ,Membrane Glycoproteins ,biology ,Brain ,biology.organism_classification ,Transmembrane protein ,medicine.anatomical_structure ,Gene Expression Regulation ,nervous system ,Synapses ,Tetherin ,RNA, Viral ,Neuron ,medicine.drug - Abstract
BST2/tetherin is a transmembrane protein with antiviral activity; it is synthesized following exposure to interferons, and restricts the release of budding virus particles by tethering them to the host cell membrane. We previously showed that BST2 is induced in primary neurons following measles virus (MV) infection or type I interferon; however, BST2 was dispensable for protection against challenge with neuron-restricted MV. Here, we define the contribution of BST-2 in neuronal MV infection. Surprisingly, and in contrast to its antiviral role in non-neuronal cells, murine BST2 promotes MV infection in brains of permissive mice and in primary neuron cultures. Moreover, BST2 expression was predominantly observed in the non-synaptic fraction of purified neurons. These studies highlight a cell-type dependent role of a well-characterized antiviral protein in enhancing neuronal infection.
- Published
- 2021
4. Abstract PS17-39: Inhibition of acetate metabolism enhances host anti-tumor immunity
- Author
-
Zachary T. Schug and Katelyn D. Miller
- Subjects
Cancer Research ,Tumor microenvironment ,Tumor hypoxia ,T cell ,Cancer ,Biology ,medicine.disease ,medicine.anatomical_structure ,Breast cancer ,Oncology ,Immunity ,Cancer cell ,medicine ,Cancer research ,Gene silencing - Abstract
Acquired resistance to anti-cancer therapy is an enormous challenge. One of the main factors contributing to therapy resistance is tumor hypoxia. The stress imposed by tumor hypoxia forces cancer cells to adapt in order to survive. These metabolically adapted cancer cells are often more invasive, more malignant, and more drug resistant. As a result, the cancer cells that emerge from hypoxic tumor regions are more likely to cause patient relapse. There is therefore a critical need to understand the mechanisms that promote the survival of cancer cells in stressful tumor microenvironments. We previously showed that the enzyme acetyl-CoA synthetase 2 (ACSS2) supports cancer cell metabolism in hypoxic and nutrient-depleted environments. ACSS2 endows cancer cells with the ability to use acetate as an alternative nutrient source to drive acetyl-CoA biosynthesis during stress and genetic silencing of ACSS2 inhibits human breast tumor growth in xenograft models. Given the important role of acetate metabolism in breast cancer we expanded upon our studies by using immunocompetent hosts and syngeneic mouse tumor models. Our results revealed a previously unknown role of ACSS2 in modulating host anti-tumor immunity. We found that ACSS2 deficient tumors are unable to grow when host immunity is intact. Depletion of host immunity (T cells) using genetic or pharmacological models rescues the growth of ACSS2 deficient tumors. Pharmacological inhibition of ACSS2 in tumors in vivo displayed gene signatures associated immune infiltration and activation within the tumor microenvironment. Moreover, ACSS2 deficient breast cancer cell lines show a marked susceptibility to T cell killing in vitro. Our current research demonstrates a novel role for acetate metabolism in supporting tumor extrinsic modulation of host anti-tumor immunity. Since activation of acetate metabolism via ACSS2 is a near universal hallmark of metabolically stressed cancer cells, targeting acetate metabolism represents an unrealized opportunity with significant upside for improving current therapeutic modalities in breast cancer. Citation Format: Katelyn Miller, Zachary T. Schug. Inhibition of acetate metabolism enhances host anti-tumor immunity [abstract]. In: Proceedings of the 2020 San Antonio Breast Cancer Virtual Symposium; 2020 Dec 8-11; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2021;81(4 Suppl):Abstract nr PS17-39.
- Published
- 2021
5. MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer
- Author
-
Johan Vande Voorde, Caroline Perry, Ann Hedley, Richard Schlegel, Mairi E. Sandison, David W. Speicher, Tony McBryan, Zachary T. Schug, Susan Chalmers, Peter D. Adams, Adam J. Cohen-Nowak, Qin Liu, Eyal Gottlieb, Andrew V. Kossenkov, Hsin-Yao Tang, Jessica C. Casciano, Katelyn D. Miller, John G. McCarron, Nicole Gorman, Qifeng Zhang, Michael J.O. Wakelam, Xuefeng Liu, and Thomas Beer
- Subjects
RM ,Cancer Research ,Epithelial-Mesenchymal Transition ,Triple Negative Breast Neoplasms ,PDGFRB ,Biology ,Transfection ,Article ,Proto-Oncogene Proteins c-myc ,RC0254 ,Transcriptome ,03 medical and health sciences ,chemistry.chemical_compound ,Breast cancer ,0302 clinical medicine ,Cell Line, Tumor ,Metabolomics ,Humans ,Beta oxidation ,Triple-negative breast cancer ,Cell Proliferation ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,Fatty acid metabolism ,Kinase ,digestive, oral, and skin physiology ,Fatty Acids ,Fatty acid ,Oncogenes ,Claudin-Low ,Cancer metabolism ,3. Good health ,Oncology ,chemistry ,030220 oncology & carcinogenesis ,Claudins ,Cancer research ,Female - Abstract
BackgroundRecent studies have suggested that fatty acid oxidation (FAO) is a key metabolic pathway for the growth of triple negative breast cancers (TNBCs), particularly those that have high expression of MYC. However, the underlying mechanism by which MYC promotes FAO remains poorly understood.MethodsWe used a combination of metabolomics, transcriptomics, bioinformatics, and microscopy to elucidate a potential mechanism by which MYC regulates FAO in TNBC.ResultsWe propose that MYC induces a multigenic program that involves changes in intracellular calcium signalling and fatty acid metabolism. We determined key roles for fatty acid transporters (CD36), lipases (LPL), and kinases (PDGFRB, CAMKK2, and AMPK) that each contribute to promoting FAO in human mammary epithelial cells that express oncogenic levels of MYC. Bioinformatic analysis further showed that this multigenic program is highly expressed and predicts poor survival in the claudin-low molecular subtype of TNBC, but not other subtypes of TNBCs, suggesting that efforts to target FAO in the clinic may best serve claudin-low TNBC patients.ConclusionWe identified critical pieces of the FAO machinery that have the potential to be targeted for improved treatment of patients with TNBC, especially the claudin-low molecular subtype.
- Published
- 2020
6. Targeting acetate metabolism: Achilles’ nightmare
- Author
-
Katelyn D. Miller and Zachary T. Schug
- Subjects
Cancer Research ,Tumour heterogeneity ,Acetate-CoA Ligase ,Antineoplastic Agents ,Acetates ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Neoplasms ,medicine ,Animals ,Humans ,Molecular Targeted Therapy ,Enzyme Inhibitors ,business.industry ,Comment ,Acetate metabolism ,Nightmare ,Metabolic pathway ,Treatment Outcome ,Oncology ,030220 oncology & carcinogenesis ,Cancer cell ,Cancer research ,medicine.symptom ,Altered metabolism ,business ,Metabolic Networks and Pathways - Abstract
Recent advances in our understanding of tumour heterogeneity alongside studies investigating altered metabolism within transformed tissue have identified metabolic pathways critical to cancer cell survival. Leveraging this information presents a promising new avenue for the generation of cancer-specific therapeutics and improved patient outcomes.
- Published
- 2021
7. Targeting ACSS2 with a Transition-State Mimetic Inhibits Triple-Negative Breast Cancer Growth
- Author
-
Andrew V. Kossenkov, Joshua D. Shaffer, Katherine Pniewski, Caroline Perry, Zachary T. Schug, Katelyn D. Miller, Joseph M. Salvino, Emmanuel Skordalakes, Sara B. Papp, Jessica C. Casciano, Yellamelli V.V. Srikanth, Joel Cassel, Jesse N Velasco-Silva, and Tomas M. Aramburu
- Subjects
0301 basic medicine ,Cancer Research ,Acetate-CoA Ligase ,Antineoplastic Agents ,Mice, Inbred Strains ,Triple Negative Breast Neoplasms ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Breast cancer ,Downregulation and upregulation ,Drug Stability ,In vivo ,Cell Line, Tumor ,ACSS2 ,medicine ,Animals ,Humans ,Molecular Targeted Therapy ,Enzyme Inhibitors ,Triple-negative breast cancer ,Fatty acid synthesis ,Chemistry ,Fatty Acids ,medicine.disease ,Xenograft Model Antitumor Assays ,In vitro ,Gene Expression Regulation, Neoplastic ,Molecular Docking Simulation ,030104 developmental biology ,HEK293 Cells ,Oncology ,030220 oncology & carcinogenesis ,Cancer cell ,Cancer research ,Female ,Drug Screening Assays, Antitumor - Abstract
Acetyl-CoA is a vitally important and versatile metabolite used for many cellular processes including fatty acid synthesis, ATP production, and protein acetylation. Recent studies have shown that cancer cells upregulate acetyl-CoA synthetase 2 (ACSS2), an enzyme that converts acetate to acetyl-CoA, in response to stresses such as low nutrient availability and hypoxia. Stressed cancer cells use ACSS2 as a means to exploit acetate as an alternative nutrient source. Genetic depletion of ACSS2 in tumors inhibits the growth of a wide variety of cancers. However, there are no studies on the use of an ACSS2 inhibitor to block tumor growth. In this study, we synthesized a small-molecule inhibitor that acts as a transition-state mimetic to block ACSS2 activity in vitro and in vivo. Pharmacologic inhibition of ACSS2 as a single agent impaired breast tumor growth. Collectively, our findings suggest that targeting ACSS2 may be an effective therapeutic approach for the treatment of patients with breast cancer. Significance: These findings suggest that targeting acetate metabolism through ACSS2 inhibitors has the potential to safely and effectively treat a wide range of patients with cancer.
- Published
- 2020
8. Immune-Mediated Control of a Dormant Neurotropic RNA Virus Infection
- Author
-
Katelynn A Milora, Kevin J. O'Regan, Christine M. Matullo, Riley Williams, Glenn F. Rall, and Katelyn D. Miller
- Subjects
Central Nervous System ,Male ,Sindbis virus ,viruses ,Immunology ,Mice, Transgenic ,medicine.disease_cause ,Microbiology ,Measles virus ,Mice ,03 medical and health sciences ,RNA Virus Infections ,0302 clinical medicine ,Immune system ,Virology ,medicine ,Animals ,RNA Viruses ,030304 developmental biology ,Neurons ,0303 health sciences ,biology ,Rabies virus ,Brain ,RNA ,RNA virus ,Acquired immune system ,biology.organism_classification ,Disease Models, Animal ,Viral replication ,Insect Science ,Pathogenesis and Immunity ,Female ,030217 neurology & neurosurgery ,Measles - Abstract
Genomic material from many neurotropic RNA viruses (e.g., measles virus [MV], West Nile virus [WNV], Sindbis virus [SV], rabies virus [RV], and influenza A virus [IAV]) remains detectable in the mouse brain parenchyma long after resolution of the acute infection. The presence of these RNAs in the absence of overt central nervous system (CNS) disease has led to the suggestion that they are viral remnants, with little or no potential to reactivate. Here we show that MV RNA remains detectable in permissive mouse neurons long after challenge with MV and, moreover, that immunosuppression can cause RNA and protein synthesis to rebound, triggering neuropathogenesis months after acute viral control. Robust recrudescence of viral transcription and protein synthesis occurs after experimental depletion of cells of the adaptive immune response and is associated with a loss of T resident memory (T(rm)) lymphocytes within the brain. The disease associated with loss of immune control is distinct from that seen during the acute infection: immune cell-depleted, long-term-infected mice display severe gait and motor problems, in contrast to the wasting and lethal disease that occur during acute infection of immunodeficient hosts. These results illuminate the potential consequences of noncytolytic, immune-mediated viral control in the CNS and demonstrate that what were once considered “resolved” RNA viral infections may, in fact, induce diseases later in life that are distinct from those caused by acute infection. IMPORTANCE Viral infections of neurons are often not cytopathic; thus, once-infected neurons survive, and viral RNAs can be detected long after apparent viral control. These RNAs are generally considered viral fossils, unlikely to contribute to central nervous system (CNS) disease. Using a mouse model of measles virus (MV) neuronal infection, we show that MV RNA is maintained in the CNS of infected mice long after acute control and in the absence of overt disease. Viral replication is suppressed by the adaptive immune response; when these immune cells are depleted, viral protein synthesis recurs, inducing a CNS disease that is distinct from that observed during acute infection. The studies presented here provide the basis for understanding how persistent RNA infections in the CNS are controlled by the host immune response, as well as the pathogenic consequences of noncytolytic viral control.
- Published
- 2019
9. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate
- Author
-
Paul M. Titchenell, Zachary T. Schug, Steven Zhao, Alessandro Carrer, Kahealani Uehara, Kathryn E. Wellen, Sophie Trefely, Michael Gilbert, Joshua D. Rabinowitz, Xianfeng Zeng, Nathaniel W. Snyder, Terence P. Gade, Cholsoon Jang, Luke Izzo, Joyce Liu, Katelyn D. Miller, and Sully Fernandez
- Subjects
0301 basic medicine ,Male ,Sucrose ,food.ingredient ,ATP citrate lyase ,Dietary Sugars ,Acetate-CoA Ligase ,Fructose ,Acetates ,Citric Acid ,Article ,Substrate Specificity ,03 medical and health sciences ,chemistry.chemical_compound ,Mice ,0302 clinical medicine ,food ,Acetyl Coenzyme A ,ACSS2 ,Animals ,Multidisciplinary ,Lipogenesis ,Fatty Acids ,Metabolism ,Gastrointestinal Microbiome ,Corn syrup ,030104 developmental biology ,chemistry ,Biochemistry ,Gene Expression Regulation ,Liver ,ATP Citrate (pro-S)-Lyase ,Hepatocytes ,Isotope Labeling ,030220 oncology & carcinogenesis ,Fructolysis - Abstract
Consumption of fructose has risen markedly in recent decades owing to the use of sucrose and high-fructose corn syrup in beverages and processed foods1, and this has contributed to increasing rates of obesity and non-alcoholic fatty liver disease2-4. Fructose intake triggers de novo lipogenesis in the liver4-6, in which carbon precursors of acetyl-CoA are converted into fatty acids. The ATP citrate lyase (ACLY) enzyme cleaves cytosolic citrate to generate acetyl-CoA, and is upregulated after consumption of carbohydrates7. Clinical trials are currently pursuing the inhibition of ACLY as a treatment for metabolic diseases8. However, the route from dietary fructose to hepatic acetyl-CoA and lipids remains unknown. Here, using in vivo isotope tracing, we show that liver-specific deletion of Acly in mice is unable to suppress fructose-induced lipogenesis. Dietary fructose is converted to acetate by the gut microbiota9, and this supplies lipogenic acetyl-CoA independently of ACLY10. Depletion of the microbiota or silencing of hepatic ACSS2, which generates acetyl-CoA from acetate, potently suppresses the conversion of bolus fructose into hepatic acetyl-CoA and fatty acids. When fructose is consumed more gradually to facilitate its absorption in the small intestine, both citrate cleavage in hepatocytes and microorganism-derived acetate contribute to lipogenesis. By contrast, the lipogenic transcriptional program is activated in response to fructose in a manner that is independent of acetyl-CoA metabolism. These data reveal a two-pronged mechanism that regulates hepatic lipogenesis, in which fructolysis within hepatocytes provides a signal to promote the expression of lipogenic genes, and the generation of microbial acetate feeds lipogenic pools of acetyl-CoA.
- Published
- 2019
10. Bst2/Tetherin Is Induced in Neurons by Type I Interferon and Viral Infection but Is Dispensable for Protection against Neurotropic Viral Challenge
- Author
-
Glenn F. Rall, Sarah E. Cavanaugh, Alicia M. Holmgren, and Katelyn D. Miller
- Subjects
Gene Expression Regulation, Viral ,Viral pathogenesis ,Viral budding ,Blotting, Western ,Immunology ,Antiviral protein ,Fluorescent Antibody Technique ,Cellular Response to Infection ,Biology ,Hippocampus ,Microbiology ,Mice ,Viral envelope ,Antigens, CD ,Viral entry ,Interferon ,Virology ,medicine ,Animals ,Cells, Cultured ,DNA Primers ,Neurons ,Analysis of Variance ,Membrane Glycoproteins ,Reverse Transcriptase Polymerase Chain Reaction ,Measles virus ,Insect Science ,Interferon Type I ,Tetherin ,Interferon type I ,Measles ,medicine.drug - Abstract
In permissive mouse central nervous system (CNS) neurons, measles virus (MV) spreads in the absence of hallmark viral budding or neuronal death, with transmission occurring efficiently and exclusively via the synapse. MV infection also initiates a robust type I interferon (IFN) response, resulting in the synthesis of a large number of genes, including bone marrow stromal antigen 2 (Bst2)/tetherin/CD317. Bst2 restricts the release of some enveloped viruses, but to date, its role in viral infection of neurons has not been assessed. Consequently, we investigated how Bst2 was induced and what role it played in MV neuronal infection. The magnitude of induction of neuronal Bst2 RNA and protein following IFN exposure and viral infection was notably higher than in similarly treated mouse embryo fibroblasts (MEFs). Bst2 synthesis was both IFN and Stat1 dependent. Although Bst2 prevented MV release from nonneuronal cells, its deletion had no effect on viral pathogenesis in MV-challenged mice. Our findings underscore how cell-type-specific differences impact viral infection and pathogenesis. IMPORTANCE Viral infections of the central nervous system can lead to debilitating disease and death. Moreover, it is becoming increasingly clear that nonrenewable cells, including most central nervous system neurons, combat neurotropic viral infections in fundamentally different ways than other rapidly dividing and renewable cell populations. Here we identify type I interferon signaling as a key inducer of a known antiviral protein (Bst2) in neurons. Unexpectedly, the gene is dispensable for clearance of neurotropic viral infection despite its well-defined contribution to limiting the spread of enveloped viruses in proliferating cells. A deeper appreciation of the importance of cell type heterogeneity in antiviral immunity will aid in the identification of unique therapeutic targets for life-threatening viral infections.
- Published
- 2015
11. What Kaplan-Meier survival curves don't tell us about CNS disease
- Author
-
Glenn F. Rall and Katelyn D. Miller
- Subjects
0301 basic medicine ,Central Nervous System ,Immunology ,Mice, Transgenic ,Disease ,Kaplan-Meier Estimate ,Receptor, Interferon alpha-beta ,Biology ,Measles ,Article ,Zika virus ,Membrane Cofactor Protein ,03 medical and health sciences ,Interferon-gamma ,Mice ,medicine ,Immunology and Allergy ,Animals ,Humans ,Kaplan-Meier Survival Curves ,Cns function ,medicine.disease ,biology.organism_classification ,Disease Models, Animal ,030104 developmental biology ,STAT1 Transcription Factor ,Neurology ,Vaccination coverage ,Central Nervous System Viral Diseases ,Neuropathogenesis ,Neurology (clinical) ,Cns disease - Abstract
Central nervous system consequences of viral infections are rare, but when they do occur, they are often serious and clinically challenging to manage. Our awareness of the perils of neuroinvasion by viruses is growing: the recently appreciated impact of Ebola and Zika virus infections on CNS integrity, decreases in vaccination coverage for potentially neurotropic viruses such as measles, and increased neurovirulence of some influenza strains collectively highlight the need for a better understanding of the viral-neural interaction. Defining these interactions and how they result in neuropathogenesis is paramount for the development of better clinical strategies, especially given the limited treatment options that are available due to the unique physiology of the brain that limits migration of blood-borne molecules into the CNS parenchyma. In this perspective, we discuss some unique aspects of neuronal viral infections and immune-mediated control that impact the pathogenic outcomes of these infections. Further, we draw attention to an often overlooked aspect of neuropathogenesis research: that lack of overt disease, which is often equated with survival post-infection, likely only scratches the surface of the myriad ways by which neurotropic infections can impair CNS function.
- Published
- 2017
12. ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells
- Author
-
Amal Robay, Catherine Kebler, Michael J. Hubbard, Wusheng Yan, Laurence Suaud, Susan H. Guttentag, Ronald C. Rubenstein, Lora Alvey, James L. Kreindler, and Katelyn D. Miller
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,Cystic Fibrosis ,Xenopus ,Cystic Fibrosis Transmembrane Conductance Regulator ,Biology ,Endoplasmic Reticulum ,Biochemistry ,Cystic fibrosis ,medicine ,Animals ,Humans ,Biotinylation ,ΔF508 ,Molecular Biology ,Heat-Shock Proteins ,Ions ,Differential display ,Endoplasmic reticulum ,Cell Membrane ,Wild type ,Epithelial Cells ,Cell Biology ,respiratory system ,medicine.disease ,Molecular biology ,Phenylbutyrates ,Cystic fibrosis transmembrane conductance regulator ,digestive system diseases ,Cell biology ,respiratory tract diseases ,Electrophysiology ,Cytosol ,Protein Transport ,Protein Synthesis and Degradation ,biology.protein ,Oocytes ,Intracellular - Abstract
Sodium 4-phenylbutyrate (4PBA) improves the intracellular trafficking of ΔF508-CFTR in cystic fibrosis (CF) epithelial cells. The underlying mechanism is uncertain, but 4PBA modulates the expression of some cytosolic molecular chaperones. To identify other 4PBA-regulated proteins that might regulate ΔF508-CFTR trafficking, we performed a differential display RT-PCR screen on IB3-1 CF bronchiolar epithelial cells exposed to 4PBA. One transcript up-regulated by 4PBA encoded ERp29, a luminal resident of the endoplasmic reticulum (ER) thought to be a novel molecular chaperone. We tested the hypothesis that ERp29 is a 4PBA-regulated ER chaperone that influences ΔF508-CFTR trafficking. ERp29 mRNA and protein expression was significantly increased (∼1.5-fold) in 4PBA-treated IB3-1 cells. In Xenopus oocytes, ERp29 overexpression increased the functional expression of both wild-type and ΔF508-CFTR over 3-fold and increased wild-type cystic fibrosis transmembrane conductance regulator (CFTR) plasma membrane expression. In CFBE41o− WT-CFTR cells, expression of and short circuit currents mediated by CFTR decreased upon depletion of ERp29 as did maturation of newly synthesized CFTR. In IB3-1 cells, ΔF508-CFTR co-immunoprecipitated with endogenous ERp29, and overexpression of ERp29 led to increased ΔF508-CFTR expression at the plasma membrane. These data suggest that ERp29 is a 4PBA-regulated ER chaperone that regulates WT-CFTR biogenesis and can promote ΔF508-CFTR trafficking in CF epithelial cells.
- Published
- 2011
13. Regulation of ENaC by ERp29
- Author
-
Katelyn D. Miller, Laurence Suaud, Ronald C. Rubenstein, Chi‐Chun Tina Chang, and Yael Grumbach
- Subjects
Epithelial sodium channel ,Chemistry ,Genetics ,Molecular Biology ,Biochemistry ,Biotechnology ,Cell biology - Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.